Send us Feedback

Peregrine Pharmaceuticls (PPHMD)
Analysis
SUMMARY
BULLS
BEARS
TOPICS
Data
DATA CENTRAL
STOCK CHART
Financials
SEC FILINGS
BALANCE
INCOME
CASH FLOW
 
 
 
 
⟩





⟩





⟩





⟩





⟩





⟩





⟩
Balance Sheet    (USD)
Annual | Quarterly
QUARTER ENDING 31-JAN
2012		 30-APR
2012		 31-JUL
2012		 31-OCT
2012		 31-JAN
2013
Cash & Equivalents 19.8M 18.0M 19.0M 24.4M 26.3M
Short Term Investments 0 0 0 0 0
Accounts Receivable 2.08M 2.35M 2.27M 2.32M 1.98M
Inventories 2.74M 3.61M 5.74M 5.43M 4.63M
Pre-paid Expenses 1.24M 795K 887K 885K 878K
Deferred Tax Assets 0 0 0 0 0
Other Current Assets 0 0 0 0 0
Total Current Assets 25.8M 24.8M 27.9M 33.1M 33.8M
Property, Plant & Equipment 2.66M 2.90M 2.87M 2.68M 2.78M
Goodwill & Intangibles 0 0 0 0 0
Other Long-term Assets 960K 570K 745K 771K 623K
Total Long-Term Assets 3.62M 3.47M 3.61M 3.45M 3.41M
Total Assets 29.4M 28.3M 31.5M 36.5M 37.2M
Accounts Payable 3.94M 3.49M 4.15M 3.18M 1.62M
Accrued Expenses 0 0 0 0 0
Short Term Debt 0 0 0 0 0
Other Current Liabilities 6.12M 9.57M 17.6M 15.8M 12.7M
Total Current Liabilities 15.2M 17.6M 26.6M 22.9M 18.8M
Long Term Debt 0 0 0 0 0
Capital Lease Obligations 0 0 0 0 0
Deferred Income Tax 0 0 0 0 0
Other Long-term Liabilities 1.34M 1.14M 1.03M 926K 991K
Total Long-term Liabilities 1.34M 1.14M 1.03M 926K 991K
Minority Interest 0 0 0 0 0
Total Liabilities 16.5M 18.8M 27.6M 23.9M 19.8M
Preferred Stock 0 0 0 0 0
Common Par 93.0K 101K 104K 123K 134K
Additional Paid-In Capital 340M 348M 350M 367M 377M
Retained Earnings -327M -338M -346M -355M -359M
Treasury Stock 0 0 0 0 0
Other Equity 0 0 0 0 0
Total Shareholder's Equity 12.9M 9.48M 3.92M 12.7M 17.4M
⟩





⟩





⟩





⟩





⟩





⟩





⟩
 
⟩





⟩





⟩





⟩





⟩





⟩





⟩
 
⟩





⟩





⟩





⟩





⟩





⟩





⟩
 
⟩





⟩





⟩





⟩





⟩





⟩





⟩
Data Sources:
Market and financial statement data provided by NASDAQ, BATS Exchange, SEC and Xignite Inc. Industry and operating metrics collected from company filings via EDGAR online. For more information on sources and calculations click here.
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki